Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conjuran vs Hyruan in Knee Osteoarthritis
NCT07646483Not yet recruiting
- Sponsor
- PharmaResearch
- Start
- Jun 2026
- Primary completion
- Sep 2027
01
Overview
Randomised, double-blind trial of polynucleotide sodium in knee osteoarthritis (OA) (2 arms), sponsored by PharmaResearch. Primary endpoint: Weight-Bearing Pain Visual Analog Scale at 16 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
polynucleotide sodium
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07646483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07646483.